verve therapeutics stock forecast

About the Verve Therapeutics Inc stock forecast. The last closing price of the Verve Therapeutics Inc share was 3296 and has changed by 185 since the penultimate trading day.


Cathie Wood Goes Shopping For Biotech 3 Stocks She Just Bought Nasdaq

Find real-time VERV - Verve Therapeutics Inc stock quotes company profile news and forecasts from CNN Business.

. View Verve Therapeutics Inc VERV investment stock information. VERV tanked after the FDA placed a hold on its investigational new drug. Verve Therapeutics Inc which has a market valuation of 128 billion.

Verve Therapeutics Stock Prediction. As of 2022 October 27 Thursday current price of VERV stock is 37000 and our data indicates that the asset price has been in a. This compares to loss of 047 per.

In the short term. VERV IEX Real-Time Price USD 2175-954 -3049 At. See Verve Therapeutics Inc.

VERV Stock Price Prediction. Based on 6 Wall Street analysts offering 12 month price targets for Verve Therapeutics in the last 3 months. Verve Therapeutics Market Cap.

The average Verve Therapeutics stock price prediction forecasts a. Analysts tracking VERV have forecast the quarterly EPS to shrink by -065 per share this quarter while. Shares of clinical-stage biotechnology company Verve Therapeutics Inc.

Verve Therapeutics Inc. 2 days agoVerve Therapeutics VERV came out with a quarterly loss of 079 per share versus the Zacks Consensus Estimate of a loss of 075. Wall Street Stock Market Finance report prediction for the future.

The average price target is 5117 with a high. Get the latest Verve Therapeutics Inc VERV detailed stock quotes stock data Real-Time ECN. The forecasts range from a low of 3600 to a high of 7500.

Verve Therapeutics Inc. VERV stock forecast Our latest prediction for Verve Therapeutics Incs stock price was made on the July 15 2022 when the stock price was at 2371. VERV stock analyst estimates including earnings and revenue EPS upgrades and downgrades.

Verve Tanks on Update. According to 15 stock analysts the. Youll find the Verve Therapeutics share forecasts stock quote and buy sell signals below.

The current Verve Therapeutics VERV share price is 3232. On average Wall Street analysts predict. NASDAQVERV - Get Rating - Analysts at Jefferies Financial Group cut their FY2022 earnings estimates for shares of Verve Therapeutics in a.

That Verve Therapeuticss share price could reach 5200 by Oct 6 2023. The Score for VERV is 54 which is 8 above its historic median score of 50 and infers lower risk than normal. The Score for VERV is 43 which is 14 below its historic median score of 50 and infers higher risk than normal.

The forecast for the further price. The current Verve Therapeutics VERV share price is 3634. Based on short-term price targets offered by six analysts the average price target for Verve Therapeutics comes to 5433.

Verve Therapeutics Stock Prediction.


Gene Editing Biotech Verve Indicates A Swift Swerve Onto Wall Street Asking For 100m Ipo Fierce Biotech


Markets Cmn Markets September 2021 Crispr Stocks And Market News


Verve Therapeutics Inc To Post Q3 2022 Earnings Of 0 76 Per Share Lifesci Capital Forecasts Nasdaq Verv Defense World


Tril Stock Forecast Price News Trillium Therapeutics


Verve Therapeutics Pioneering Cardiovascular Medicine Using The Power Of Gene Editing Seeking Alpha


Markets Cmn Markets October 2021 Crispr Stocks And Market News


S 1


Illumina Launches A New Line Of High End Dna Sequencers Stat


Jpm Verve Therapeutics Unveils Its Lead Program A One And Done Treatment For Genetic High Cholesterol Fierce Biotech


58 Biggest Movers From Friday Markets Insider


G Frrc66uxpwhm


Verve S Stock Price Could Continue To Rise Through Clinical Progress Despite Worries About Deeperpocketed Competition


Verve Therapeutics Inc Verv Stock Price Quote News Stock Analysis


Zootf4dkfwom M


Verve Therapeutics Earnings Revenue Miss In Q3 Investing Com India


Verve Therapeutics Pioneering Cardiovascular Medicine Using The Power Of Gene Editing Seeking Alpha


Cathie Wood Doubles Down On These 2 Innovation Stocks


Verve Therapeutics Protecting The World From Heart Disease


G Frrc66uxpwhm

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel